Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Moodys
Daiichi Sankyo
Farmers Insurance
Queensland Health

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,375,978

« Back to Dashboard

Summary for Patent: 6,375,978
Title: Rate controlling membranes for controlled drug delivery devices
Abstract:This invention provides rate controlling membranes for controlled drug delivery devices that are stable over time and exhibit more predictable and consistent membrane functionality. According to another aspect, the membranes have enhanced permeability. According to the invention, the rate controlling membrane of a controlled drug delivery device is subjected to a pre-treatment annealing process wherein it is subjected to an elevated temperature for a predetermined time period and subsequently cooled to ambient conditions before incorporation into a controlled drug delivery device.
Inventor(s): Kleiner; Lothar W. (Los Altos, CA), Gale; Robert M. (Los Altos, CA), Berggren; Randall G. (Livermore, CA), Tong; Gilbert T. (Union City, CA), Chen; Guohua (Sunnyvale, CA), Dionne; Keith E. (Cambridge, MA), Houston; Paul R. (Hayward, CA)
Assignee: ALZA Corporation (Mountain View, CA)
Application Number:09/213,213
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,375,978
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

Drugs Protected by US Patent 6,375,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Medtronic
Cantor Fitzgerald
UBS
Argus Health
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.